Protein changes in CSF of HIV-infected patients: Evidence for loss of neuroprotection

Journal of NeuroVirology

Volumn 17, Issue 3, 2011, Pages 258-273

  Meeker, Rick B ^a   Poulton, Winona ^a,b   Markovic Plese, Silva ^a   Hall, Colin ^a   Robertson, Kevin ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

Brain; Chemokine; Cytokine; Dementia; Inflammation; Neurotrophin

Indexed keywords

ADIPONECTIN; ANGIOGENIN; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR 2; CONNECTIVE TISSUE GROWTH FACTOR 6; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FRACTALKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1DELTA; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPROTEGERIN; PROTEIN; SCATTER FACTOR; SOMATOMEDIN BINDING PROTEIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; UROKINASE RECEPTOR;

ADULT; ARTICLE; BRAIN DAMAGE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MALE; NEUROPROTECTION; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION DISORDERS; CYTOKINES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HIV; HIV INFECTIONS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; NEUROPSYCHOLOGICAL TESTS; NEUROTROPHIN 3; PROTEIN ARRAY ANALYSIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SEVERITY OF ILLNESS INDEX; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 79959978322     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-011-0034-5     Document Type: Article

References (83)

1. Achim CL, Heyes MP, Wiley CA (1993) Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest 91:2769-2775 (Pubitemid 23182534)
2. Albrecht D, Garcia L, Cartier L, Kettlun AM, Vergara C, Collados L, Valenzuela MA (2006) Trophic factors in cerebrospinal fluid and spinal cord of patients with tropical spastic paraparesis, HIV, and Creutzfeldt-Jakob disease. AIDS Res Hum Retroviruses 22:248-254
3. Axelsson J, Heimburger O, Lindholm B, Stenvinkel P (2005) Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr 15:131-136 (Pubitemid 40093697)
4. Bachis A, Mocchetti I (2005) Brain-derived neurotrophic factor is neuroprotective against human immunodeficiency virus-1 envelope proteins. Ann NY Acad Sci 1053:247-257 (Pubitemid 43031104)
5. Bandaru VV, McArthur JC, Sacktor N, Cutler RG, Knapp EL, Mattson MP, Haughey NJ (2007) Associative and predictive biomarkers of dementia in HIV-1-infected patients. Neurology 68:1481-1487 (Pubitemid 46685918)
6. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ (1997) Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28:1233-1244 (Pubitemid 27248902)
7. Bazan NG, Marcheselli VL, Cole-Edwards K (2005) Brain response to injury and neurodegeneration: endogenous neuroprotective signaling. Ann NY Acad Sci 1053:137-147 (Pubitemid 43031090)
8. Berg AH, Combs TP, Scherer PE (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84-89 (Pubitemid 36740452)
9. Bouwman FH, Skolasky RL, Hes D, Selnes OA, Glass JD, Nance-Sproson TE, Royal W, Dal Pan GJ, McArthur JC (1998) Variable progression of HIV-associated dementia. Neurology 50:1814-1820 (Pubitemid 28283257)
10. Bragg DC, Robertson K, Hall CD, Meeker RB (2000) Techniques to measure neurologic disease progression in HIV-1 patients. Science Online: NeuroAIDS 3:1-9
11. Brew BJ, Pemberton L, Blennow K, Wallin A, Hagberg L (2005) CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology 65:1490-1492 (Pubitemid 41552790)
12. Bronzetti E, Artico M, Kovacs I, Felici LM, Magliulo G, Vignone D, D'Ambrosio A, Forte F, Di Liddo R, Feher J (2007) Expression of neurotransmitters and neurotrophins in neurogenic inflammation of the rat retina. Eur J Histochem 51:251-260
13. Cinque P, Vago L, Mengozzi M, Torri V, Ceresa D, Vicenzi E, Transidico P, Vagani A, Sozzani S, Mantovani A, Lazzarin A, Poli G (1998) Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 12:1327-1332 (Pubitemid 28330725)
14. Cinque P, Nebuloni M, Santovito ML, Price RW, Gisslen M, Hagberg L, Bestetti A, Vago G, Lazzarin A, Blasi F, Sidenius N (2004) The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations. Ann Neurol 55:687-694 (Pubitemid 38544329)
15. Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998) Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 95:3117-3121 (Pubitemid 28135864)
16. Conant K, McArthur JC, Griffin DE, Sjulson L, Wahl LM, Irani DN (1999) Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol 46:391-398 (Pubitemid 29416277)
17. Elkabes S, DiCicco-Bloom EM, Black IB (1996) Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J Neurosci 16:2508-2521 (Pubitemid 26122673)
18. Elovaara I, Muller KM (1993) Cytoimmunological abnormalities in cerebrospinal fluid in early stages of HIV-1 infection often precede changes in blood. J Neuroimmunol 44:199-204 (Pubitemid 23161399)
19. Emsley HC, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, Illingworth K, Scarth S, Wickramasinghe V, Hoadley ME, Rothwell NJ, Tyrrell PJ, Hopkins SJ (2007) Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurol 7:5
20. Enting RH, Foudraine NA, Lange JM, Jurriaans S, van der PT, Weverling GJ, Portegies P (2000) Cerebrospinal fluid beta2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine. J Neuroimmunol 102:216-221
21. Epstein L, Gendelman H (1993) Human immunodeficiency virus type 1 infection of the nervous system: pathogenic mechanisms. Ann Neurol 33:429-436 (Pubitemid 23143022)
22. Giralt M, Domingo P, Guallar JP, Rodriguez de la Concepcion ML, Alegre M, Domingo JC, Villarroya F (2006) HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV-1/HAART-associated lipodystrophy. Antivir Ther 11:729-740 (Pubitemid 44497168)
23. Gisslen M, Hagberg L, Brew BJ, Cinque P, Price RW, Rosengren L (2007) Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. J Infect Dis 195:1774-1778 (Pubitemid 46870250)
24. Giulian D, Noonan CA (1998) Neurotoxins from HIV-infected mononuclear phagocytes. In: Gendelman HE, Lipton SAEL, Swindells S (eds) The neurology of AIDS. International Thompson, New York, pp 117-129
25. Giulian D, Yu J, Li X, Tom D, Li J, Wendt E, Lin S-N, Schwarcz R, Noonan C (1996) Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J Neurosci 16:3139-3153 (Pubitemid 26142350)
26. Gora-Kupilas K, Josko J (2005) The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol 43:31-39 (Pubitemid 40533190)
27. Groneberg DA, Fischer TC, Peckenschneider N, Noga O, Dinh QT, Welte T, Welker P (2007) Cell type-specific regulation of brainderived neurotrophic factor in states of allergic inflammation. Clin Exp Allergy 37:1386-1391 (Pubitemid 47372296)
28. Hagberg L, Fuchs D, Rosengren L, Gisslen M (2000) Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients. J Neuroimmunol 102:51-55
29. Heyes MP, Brew B, Martin A, Markey SP, Price RW, Bhalla RB, Salazar A (1991) Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Adv Exp Med Biol 294:687-690
30. Huang JS, Letendre S, Marquie-Beck J, Cherner M, McCutchan JA, Grant I, Ellis R (2007) Low CSF leptin levels are associated with worse learning and memory performance in HIV-infected men. J Neuroimmune Pharmacol 2:352-358
31. Hult B, Chana G, Masliah E, Everall I (2008) Neurobiology of HIV. Int Rev Psychiatry 20:3-13 (Pubitemid 351196198)
32. Husson I, Rangon CM, Lelievre V, Bemelmans AP, Sachs P, Mallet J, Kosofsky BE, Gressens P (2005) BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cereb Cortex 15:250-261 (Pubitemid 40270194)
33. Johnston JB, Zhang K, Silva C, Shalinsky DR, Conant K, Ni W, Corbett D, Yong VW, Power C (2001) HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann Neurol 49:230-241 (Pubitemid 32157999)
34. Jostock T, Mullberg J, Ozbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF, Rose-John S (2001) Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 268:160-167 (Pubitemid 32052260)
35. Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE (1998) Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 44:831-835 (Pubitemid 28516058)
36. Kilic E, Kilic U, Hermann DM (2005) TAT-GDNF in neurodegeneration and ischemic stroke. CNS Drug Rev 11:369-378
37. Kilic E, Kilic U, Wang Y, Bassetti CL, Marti HH, Hermann DM (2006) The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J 20:1185-1187
38. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P (2005) Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112:1756-1762 (Pubitemid 41372115)
39. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093 (Pubitemid 16032241)
40. Kolson DL (2002) Neuropathogenesis of central nervous system HIV-1 infection. Clin Lab Med 22:703-717 (Pubitemid 35014996)
41. Krabbe KS, Mortensen EL, Avlund K, Pedersen AN, Pedersen BK, Jorgensen T, Bruunsgaard H (2009) Brain-derived neurotrophic factor predicts mortality risk in older women. J Am Geriatr Soc 57:1447-1452
42. Leveque T, Le Pavec G, Boutet A, Tardieu M, Dormont D, Gras G (2004) Differential regulation of gelatinase A and B and TIMP-1 and-2 by TNF-alpha and HIV virions in astrocytes. Microbes Infect 6:157-163 (Pubitemid 38293292)
43. Liuzzi GM, Mastroianni CM, Santacroce MP, Fanelli M, D'Agostino C, Vullo V, Riccio P (2000) Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases. J Neurovirol 6:156-163 (Pubitemid 30303574)
44. McCoig C, Castrejon MM, Saavedra-Lozano J, Castano E, Baez C, Lanier ER, Saez-Llorens X, Ramilo O (2004) Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children. Pediatr Infect Dis J 23:114-118 (Pubitemid 38222781)
45. Meeker RB, Robertson K, Barry T, Hall C (1999) Neurotoxicity of CSF from HIV-infected humans. J Neurovirol 5:507-518 (Pubitemid 29484180)
46. Meeker RB, Boles JC, Robertson KR, Hall CD (2005) Cerebrospinal fluid from human immunodeficiency virus-infected individuals facilitates neurotoxicity by suppressing intracellular calcium recovery. J Neurovirol 11:144-156 (Pubitemid 40852422)
47. Meisner F, Scheller C, Kneitz S, Sopper S, Neuen-Jacob E, Riederer P, Meulen VT, Koutsilieri E (2008) Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology 33:2228-2236 (Pubitemid 351992085)
48. Mocchetti I, Bachis A (2004) Brain-derived neurotrophic factor activation of TrkB protects neurons from HIV-1/gp120-induced cell death. Crit Rev Neurobiol 16:51-57 (Pubitemid 39586902)
49. Nakagawa T, Suga S, Kawase T, Toda M (2006) Intracarotid injection of granulocyte-macrophage colony-stimulating factor induces neuroprotection in a rat transient middle cerebral artery occlusion model. Brain Res 1089:179-185 (Pubitemid 43766361)
50. Nawashiro H, Martin D, Hallenbeck JM (1997) Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res 778:265-271 (Pubitemid 28037406)
51. Nosheny RL, Mocchetti I, Bachis A (2005) Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration. Neurotox Res 8:187-198
52. Nosheny RL, Ahmed F, Yakovlev A, Meyer EM, Ren K, Tessarollo L, Mocchetti I (2007) Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo. Eur J Neurosci 25:2275-2284 (Pubitemid 46625935)
53. Novikova LN, Novikov LN, Kellerth JO (2000) Survival effects of BDNF and NT-3 on axotomized rubrospinal neurons depend on the temporal pattern of neurotrophin administration. Eur J Neurosci 12:776-780 (Pubitemid 30142781)
54. Padberg F, Feneberg W, Schmidt S, Schwarz MJ, Korschenhausen D, Greenberg BD, Nolde T, Muller N, Trapmann H, Konig N, Moller HJ, Hampel H (1999) CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis. J Neuroimmunol 99:218-223 (Pubitemid 29518234)
55. Pemberton LA, Brew BJ (2001) Cerebrospinal fluid S-100beta and its relationship with AIDS dementia complex. J Clin Virol 22:249-253 (Pubitemid 32846555)
56. Perrella O, Guerriero M, Izzo E, Soscia M, Carrieri PB (1992) Interleukin-6 and granulocyte macrophage-CSF in the cerebrospinal fluid from HIV infected subjects with involvement of the central nervous system. Arq Neuropsiquiatr 50:180-182
57. Poluektova L, Gorantla S, Faraci J, Birusingh K, Dou H, Gendelman HE (2004) Neuroregulatory events follow adaptive immunemediated elimination of HIV-1-infected macrophages: studies in a murine model of viral encephalitis. J Immunol 172:7610-7617 (Pubitemid 38747625)
58. Price RW, Sidtis JJ (1990) Evaluation of the AIDS dementia complex in clinical trials. J Acquir Immune Defic Syndr 3(Suppl 2):S51-S60
59. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, Scherer PE, Ahima RS (2004) Adiponectin acts in the brain to decrease body weight. Nat Med 10:524-529 (Pubitemid 38667912)
60. Robertson KR, Kapoor C, Robertson WT, Fuscus S, Ford S, Hall C (2004) No gender differences in the progression of nervous system disease of HIV infection. J Acquir Immune Defic Syndr 36:817-822 (Pubitemid 38859347)
61. Sabri F, de Milito A, Pirskanen R, Elovaara I, Hagberg L, Cinque P, Price R, Chiodi F (2001) Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex. J Neuroimmunol 114:197-206 (Pubitemid 32184742)
62. Schnydrig S, Korner L, Landweer S, Ernst B, Walker G, Otten U, Kunz D (2007) Peripheral lipopolysaccharide administration transiently affects expression of brain-derived neurotrophic factor, corticotropin and proopiomelanocortin in mouse brain. Neurosci Lett 429:69-73 (Pubitemid 350116355)
63. Sidenius N, Nebuloni M, Sala S, Zerbi P, Price RW, Gisslen M, Hagberg L, Vago L, Lazzarin A, Blasi F, Cinque P (2004) Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease. J Neuroimmunol 157:133-139 (Pubitemid 39576647)
64. Soontornniyomkij V, Wang G, Pittman CA, Wiley CA, Achim CL (1998) Expression of brain-derived neurotrophic factor protein in activated microglia of human immunodeficiency virus type 1 encephalitis. Neuropathol Appl Neurobiol 24:453-460 (Pubitemid 29002276)
65. Sporer B, Koedel U, Goebel FD, Pfister HW (2000) Increased levels of soluble Fas receptor and Fas ligand in the cerebrospinal fluid of HIV-infected patients. AIDS Res Hum Retroviruses 16:221-226 (Pubitemid 30111958)
66. Sporer B, Koedel U, Popp B, Paul R, Pfister HW (2005) Evaluation of cerebrospinal fluid uPA, PAI-1, and soluble uPAR levels in HIV-infected patients. J Neuroimmunol 163:190-194 (Pubitemid 40692963)
67. Stadelmann C, Kerschensteiner M, Misgeld T, Bruck W, Hohlfeld R, Lassmann H (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 125:75-85 (Pubitemid 34084038)
68. Storkebaum E, Lambrechts D, Carmeliet P (2004) VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26:943-954 (Pubitemid 39273068)
69. Streit WJ (2005) Microglia and neuroprotection: implications for Alzheimer's disease. Brain Res Brain Res Rev 48:234-239 (Pubitemid 40585754)
70. Suryadevara R, Holter S, Borgmann K, Persidsky R, Labenz-Zink C, Persidsky Y, Gendelman HE, Wu L, Ghorpade A (2003) Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia. Glia 44:47-56 (Pubitemid 37176319)
71. Szczepanik AM, Funes S, Petko W, Ringheim GE (2001) IL-4, IL-10 and IL-13 modulate A beta (1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol 113:49-62 (Pubitemid 32008670)
72. Towfighi A, Skolasky RL, St Hillaire C, Conant K, McArthur JC (2004) CSF soluble Fas correlates with the severity of HIV-associated dementia. Neurology 62:654-656 (Pubitemid 38252816)
73. Tsiodras S, Mantzoros C (2006) Leptin and adiponectin in the HIV associated metabolic syndrome: physiologic and therapeutic implications. Am J Infect Dis 2:141-152
74. Turchan J, Pocernich CB, Gairola C, Chauhan A, Schifitto G, Butterfield DA, Buch S, Narayan O, Sinai A, Geiger J, Berger JR, Elford H, Nath A (2003) Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 60:307-314 (Pubitemid 36152028)
75. Turrin NP, Rivest S (2006) Molecular and cellular immune mediators of neuroprotection. Mol Neurobiol 34:221-242
76. Verkauskiene R, Dollfus C, Levine M, Faye A, Deghmoun S, Houang M, Chevenne D, Bresson JL, Blanche S, Levy-Marchal C (2006) Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome. Pediatr Res 60:225-230 (Pubitemid 44297598)
77. Wang Y, Kilic E, Kilic U, Weber B, Bassetti CL, Marti HH, Hermann DM (2005) VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 128:52-63 (Pubitemid 40070520)
78. Wong ML, Bongiorno PB, Rettori V, McCann SM, Licinio J (1997) Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. Proc Natl Acad Sci USA 94:227-232 (Pubitemid 27027191)
79. Wu D (2005) Neuroprotection in experimental stroke with targeted neurotrophins. NeuroRx 2:120-128 (Pubitemid 40128032)
80. Xiong H, Zeng YC, Lewis T, Zheng J, Persidsky Y, Gendelman HE (2000) HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. J Neurovirol 6(Suppl 1):S14-S23 (Pubitemid 30342773)
81. Yabe T, Samuels I, Schwartz JP (2002) Bone morphogenetic proteins BMP-6 and BMP-7 have differential effects on survival and neurite outgrowth of cerebellar granule cell neurons. J Neurosci Res 68:161-168 (Pubitemid 34275009)
82. Yasuhara T, Shingo T, Kobayashi K, Takeuchi A, Yano A, Muraoka K, Matsui T, Miyoshi Y, Hamada H, Date I (2004) Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur J Neurosci 19:1494-1504 (Pubitemid 38437912)
83. Zheng J, Gendelman HE (1997) The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr Opin Neurol 10:319-325 (Pubitemid 27355011)